Raadi | Blue Cross MN

Soo bandhiga 2711 - 2720 ee natiijooyinka 3697

Bixiye

P7-20 Musculoskeletal Management Program Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020

Bixiye

QP99-19 Pharmacy Benefit Exclusion for Rapatha ®

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019

Bixiye

QP96-19 Pharmacy Benefit Exclusion for PolivyTM, KanjintiTM, Evenity ®, BelrapzoTM, MvasiTM, Clinolipid 20%, Cisplatin, Heparin Sodium, and Selenious acid

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019

Bixiye

QP94-19 MDH Syphilis Pregnancy Screening Guidelines

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019

Bixiye

QP104-19 Retail Health Clinics

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 11, 2019

Bixiye

QP106-19 Additional Benefit Detail Now Available via the Availity Portal for Minnesota Health Care Programs Subscribers

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 11, 2019

Bixiye

QP103-19 Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 11, 2019

Bixiye

QP82R1-19 Pharmacy Benefit Update - $0 Insulin Member Cost-Share Benefit for Commercial Lines of Business

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019

Bixiye

QP95-19 New Drug, Reyvow™ (lasmiditan) Will Require Prior Authorization (PA)

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019

Bixiye

QP93-19 Provider Cost Data Update

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019